Teladoc Health, Inc. (TDOC)
NYSE: TDOC · IEX Real-Time Price · USD
12.99
+0.18 (1.41%)
At close: May 2, 2024, 4:00 PM
12.91
-0.08 (-0.62%)
Pre-market: May 3, 2024, 8:06 AM EDT
Teladoc Health Revenue
Teladoc Health had revenue of $2.62B in the twelve months ending March 31, 2024, with 6.01% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $646.13M with 2.68% year-over-year growth. In the year 2023, Teladoc Health had annual revenue of $2.60B with 8.13% growth.
Revenue (ttm)
$2.62B
Revenue Growth
+6.01%
P/S Ratio
0.84
Revenue / Employee
$467,733
Employees
5,600
Market Cap
2.20B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.60B | 195.58M | 8.13% |
Dec 31, 2022 | 2.41B | 374.13M | 18.41% |
Dec 31, 2021 | 2.03B | 938.75M | 85.81% |
Dec 31, 2020 | 1.09B | 540.66M | 97.71% |
Dec 31, 2019 | 553.31M | 135.40M | 32.40% |
Dec 31, 2018 | 417.91M | 184.63M | 79.14% |
Dec 31, 2017 | 233.28M | 110.12M | 89.42% |
Dec 31, 2016 | 123.16M | 45.77M | 59.15% |
Dec 31, 2015 | 77.38M | 33.86M | 77.78% |
Dec 31, 2014 | 43.53M | 23.62M | 118.67% |
Dec 31, 2013 | 19.91M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Privia Health Group | 1.66B |
CONMED | 1.26B |
STAAR Surgical Company | 322.42M |
Deciphera Pharmaceuticals | 163.36M |
RxSight | 89.08M |
Kymera Therapeutics | 79.41M |
Arvinas | 78.50M |
Intellia Therapeutics | 36.28M |
TDOC News
- 1 hour ago - TDOC ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Teladoc Health, Inc. Shareholders Who Lost Money - Accesswire
- 1 day ago - Levi & Korsinsky Reminds Teladoc Investors of the Ongoing Investigation into Potential Violations of Securities Laws - TDOC - Accesswire
- 2 days ago - An Investigation Has Commenced on Behalf of Teladoc Health, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your TDOC Losses. - Accesswire
- 7 days ago - Teladoc Health Reports First Quarter 2024 Results - GlobeNewsWire
- 8 days ago - Teladoc (TDOC) stock price analysis and the fall from grace - Invezz
- 11 days ago - ATTENTION Teladoc Health, Inc. Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights - Accesswire
- 14 days ago - TDOC STOCK ALERT: Levi & Korsinsky Notifies Teladoc Health, Inc. Investors of an Ongoing Investigation - Accesswire
- 16 days ago - TDOC ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Teladoc Health, Inc. Shareholders Who Lost Money - Accesswire